These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16866649)

  • 1. Multidrug-resistant Acinetobacter: a threat to the antibiotic era.
    Peleg AY; Paterson DL
    Intern Med J; 2006 Aug; 36(8):479-82. PubMed ID: 16866649
    [No Abstract]   [Full Text] [Related]  

  • 2. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting.
    Hanlon GW
    Lett Appl Microbiol; 2005; 41(5):375-8. PubMed ID: 16238638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the way of dealing with antibiotic exposure in studies assessing risk factors for drug-resistant pathogens.
    Prates CG; Zavascki AP
    Diagn Microbiol Infect Dis; 2009 May; 64(1):102; author reply 103. PubMed ID: 19232855
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nosocomial infections caused by Acinetobacter: experience in a neonatal care unit in Casablanca].
    Nejjari N; Zerhouni F; Bouharrou A; Habzi A; Najdi T; Lahbabi M; Benomar S
    Tunis Med; 2003 Feb; 81(2):121-5. PubMed ID: 12708178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acinetobacter baumannii resistant to everything: what should we do?
    Vila J; Pachón J
    Clin Microbiol Infect; 2011 Jul; 17(7):955-6. PubMed ID: 21722248
    [No Abstract]   [Full Text] [Related]  

  • 6. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

  • 8. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species.
    Paterson DL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S43-8. PubMed ID: 16894514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.
    Perez F; Ponce-Terashima R; Adams MD; Bonomo RA
    Virulence; 2011; 2(2):86-90. PubMed ID: 21499025
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial activity of aminoglycosides against nosocomial strains of Acinetobacter baumannii isolated between 1990 and 1999].
    González G; Ramírez C; Muñoz M
    Rev Esp Quimioter; 2000 Dec; 13(4):401-4. PubMed ID: 11498707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options for Acinetobacter baumannii infections.
    Vila J; Pachón J
    Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
    Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
    Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multidrug resistant Acinetobacter baumannii].
    Nemec A
    Klin Mikrobiol Infekc Lek; 2008 Oct; 14(5):162-7. PubMed ID: 19051163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance pattern in Acinetobacter spp.--a retrospective anaysis.
    Thakur K; Sharma V
    J Commun Dis; 2006 Dec; 38(4):379-80. PubMed ID: 17913218
    [No Abstract]   [Full Text] [Related]  

  • 17. Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for Institutes.
    Chen CH; Lin LC; Chang YJ; Chen YM; Chang CY; Huang CC
    Int J Environ Res Public Health; 2015 Jul; 12(8):8871-82. PubMed ID: 26264006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter?
    Tuon FF; Rymsza AM; Penteado-Filho SR; Pilonetto M; Arend LN; Levin AS
    J Infect; 2011 Mar; 62(3):246-9. PubMed ID: 21256151
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.
    Saçar S; Turgut H; Cenger DH; Coşkun E; Asan A; Kaleli I
    J Infect Dev Ctries; 2007 Dec; 1(3):342-4. PubMed ID: 19734617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection prevention control bundle of multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus: which one is more important?
    Apisarnthanarak A; Mundy LM
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):207-8. PubMed ID: 24442090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.